These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23676274)

  • 1. Interaction of 14-3-3 proteins with the estrogen receptor alpha F domain provides a drug target interface.
    De Vries-van Leeuwen IJ; da Costa Pereira D; Flach KD; Piersma SR; Haase C; Bier D; Yalcin Z; Michalides R; Feenstra KA; Jiménez CR; de Greef TF; Brunsveld L; Ottmann C; Zwart W; de Boer AH
    Proc Natl Acad Sci U S A; 2013 May; 110(22):8894-9. PubMed ID: 23676274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designer interface peptide grafts target estrogen receptor alpha dimerization.
    Chakraborty S; Asare BK; Biswas PK; Rajnarayanan RV
    Biochem Biophys Res Commun; 2016 Sep; 478(1):116-122. PubMed ID: 27462021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of 14-3-3β in transcriptional activation of estrogen receptor α and its involvement in proliferation of breast cancer cells.
    Kim Y; Kim H; Jang SW; Ko J
    Biochem Biophys Res Commun; 2011 Oct; 414(1):199-204. PubMed ID: 21946067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation.
    Zhu J; Zhao C; Kharman-Biz A; Zhuang T; Jonsson P; Liang N; Williams C; Lin CY; Qiao Y; Zendehdel K; Strömblad S; Treuter E; Dahlman-Wright K
    Oncogene; 2014 Aug; 33(34):4340-51. PubMed ID: 24441041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERα dimerization: a key factor for the weak estrogenic activity of an ERα modulator unable to compete with estradiol in binding assays.
    Leclercq G; Laïos I; Elie-Caille C; Leiber D; Laurent G; Lesniewska E; Tanfin Z; Jacquot Y
    J Recept Signal Transduct Res; 2017 Apr; 37(2):149-166. PubMed ID: 27400858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of human estrogen receptor alpha by protein kinase A regulates dimerization.
    Chen D; Pace PE; Coombes RC; Ali S
    Mol Cell Biol; 1999 Feb; 19(2):1002-15. PubMed ID: 9891036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A transcriptional repressive role for epithelial-specific ETS factor ELF3 on oestrogen receptor alpha in breast cancer cells.
    Gajulapalli VN; Samanthapudi VS; Pulaganti M; Khumukcham SS; Malisetty VL; Guruprasad L; Chitta SK; Manavathi B
    Biochem J; 2016 Apr; 473(8):1047-61. PubMed ID: 26920025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
    Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
    Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis and dual ligand regulation of tetrameric estrogen receptor α/14-3-3ζ protein complex.
    Somsen BA; Sijbesma E; Leysen S; Honzejkova K; Visser EJ; Cossar PJ; Obšil T; Brunsveld L; Ottmann C
    J Biol Chem; 2023 Jul; 299(7):104855. PubMed ID: 37224961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF2 induces breast cancer growth through ligand-independent activation and recruitment of ERα and PRBΔ4 isoform to MYC regulatory sequences.
    Giulianelli S; Riggio M; Guillardoy T; Pérez Piñero C; Gorostiaga MA; Sequeira G; Pataccini G; Abascal MF; Toledo MF; Jacobsen BM; Guerreiro AC; Barros A; Novaro V; Monteiro FL; Amado F; Gass H; Abba M; Helguero LA; Lanari C
    Int J Cancer; 2019 Oct; 145(7):1874-1888. PubMed ID: 30843188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of glucocorticoid receptor (GR) with estrogen receptor (ER) α and activator protein 1 (AP1) in dexamethasone-mediated interference of ERα activity.
    Karmakar S; Jin Y; Nagaich AK
    J Biol Chem; 2013 Aug; 288(33):24020-34. PubMed ID: 23814048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A noncompetitive small molecule inhibitor of estrogen-regulated gene expression and breast cancer cell growth that enhances proteasome-dependent degradation of estrogen receptor {alpha}.
    Kretzer NM; Cherian MT; Mao C; Aninye IO; Reynolds PD; Schiff R; Hergenrother PJ; Nordeen SK; Wilson EM; Shapiro DJ
    J Biol Chem; 2010 Dec; 285(53):41863-73. PubMed ID: 21041310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The F domain of estrogen receptor α is involved in species-specific, tamoxifen-mediated transactivation.
    Arao Y; Korach KS
    J Biol Chem; 2018 Jun; 293(22):8495-8507. PubMed ID: 29632071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
    Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL
    Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and Molecular Mechanisms of Cytokine-Mediated Endocrine Resistance in Human Breast Cancer Cells.
    Stender JD; Nwachukwu JC; Kastrati I; Kim Y; Strid T; Yakir M; Srinivasan S; Nowak J; Izard T; Rangarajan ES; Carlson KE; Katzenellenbogen JA; Yao XQ; Grant BJ; Leong HS; Lin CY; Frasor J; Nettles KW; Glass CK
    Mol Cell; 2017 Mar; 65(6):1122-1135.e5. PubMed ID: 28306507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
    Al-Dhaheri MH; Rowan BG
    Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzothiophenone Derivatives Targeting Mutant Forms of Estrogen Receptor-α in Hormone-Resistant Breast Cancers.
    Singh K; Munuganti RSN; Lallous N; Dalal K; Yoon JS; Sharma A; Yamazaki T; Cherkasov A; Rennie PS
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29462880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptidylprolyl Isomerase Pin1 Directly Enhances the DNA Binding Functions of Estrogen Receptor α.
    Rajbhandari P; Ozers MS; Solodin NM; Warren CL; Alarid ET
    J Biol Chem; 2015 May; 290(22):13749-62. PubMed ID: 25866209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of aspartate 351 in transactivation and active conformation of estrogen receptor alpha.
    Kim JH; Lee MH; Kim BJ; Kim JH; Han SJ; Kim HY; Stallcup MR
    J Mol Endocrinol; 2005 Dec; 35(3):449-64. PubMed ID: 16326832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The F-domain of estrogen receptor-alpha inhibits ligand induced receptor dimerization.
    Yang J; Singleton DW; Shaughnessy EA; Khan SA
    Mol Cell Endocrinol; 2008 Nov; 295(1-2):94-100. PubMed ID: 18762230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.